Diasorin
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Diasorin
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics used for detecting pathogens and contamination of samples from the human body, as well as used in industrial settings such as food and water contamination testing. The company operates three segments: immunodiagnostics (66% of sales), molecular diagnostics (17%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment’s importance has decreased over the years, and in 2024, it accounted for only 2% of total sales.
Others were interested in
See all stocksFrequently asked questions
To buy Diasorin stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Diasorin by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Diasorin is DIAS:xmil. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Diasorin has its primary listing on Borsa Italiana/Milan Stock Exchange. You can trade Diasorin with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Diasorin is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Diasorin as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Diasorin.